The three MHRA-approved injection sites are the abdomen (at least 5 cm from the navel), the front or outer thigh, and the outer back area of the upper arm
However, meaningful weight loss often begins appearing at lower maintenance doses (1.7 mg to 2.0 mg), and not everyone requires the highest available dose to reach their goals
Semaglutide Misuse in Atypical Anorexia NervosaA Case Report
TB-500's parent Thymosin -4 has been characterised across actin-cytoskeleton dynamics, cell migration, cardiac progenitor mobilisation, and corneal wound-healing (PMID 11579089, PMID 15565145, PMID 27450738)
(PubMed) Fleischauer AT, Poole C, Arab L
Comprehensive in vivo and in vitro studies demonstrated its effect in the prevention of neuronal loss and promotion of motor neuron survival, even after the onset of symptoms